DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:CPR - NL0015435975 - Common Stock
5.75 EUR
-0.06 (-1%)
Overall CPR gets a fundamental rating of 4 out of 10. We evaluated CPR against 31 industry peers in the Beverages industry. CPR has an average financial health and profitability rating. While showing a medium growth rate, CPR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year CPR was profitable.
CPR had a positive operating cash flow in the past year.
CPR had positive earnings in each of the past 5 years.
In the past 5 years CPR always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of CPR (2.51%) is worse than 64.52% of its industry peers.
CPR has a Return On Equity of 5.44%. This is in the lower half of the industry: CPR underperforms 67.74% of its industry peers.
CPR has a Return On Invested Capital (7.03%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CPR is in line with the industry average of 8.05%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROIC | 7.03% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
CPR has a Profit Margin (6.57%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CPR has declined.
With a decent Operating Margin value of 21.32%, CPR is doing good in the industry, outperforming 61.29% of the companies in the same industry.
CPR's Operating Margin has been stable in the last couple of years.
The Gross Margin of CPR (57.55%) is better than 77.42% of its industry peers.
CPR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
The number of shares outstanding for CPR has been increased compared to 1 year ago.
CPR has more shares outstanding than it did 5 years ago.
CPR has about the same debt/assets ratio as last year.
2.2 Solvency
CPR has an Altman-Z score of 2.56. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
CPR's Altman-Z score of 2.56 is fine compared to the rest of the industry. CPR outperforms 70.97% of its industry peers.
CPR has a debt to FCF ratio of 8.49. This is a slightly negative value and a sign of low solvency as CPR would need 8.49 years to pay back of all of its debts.
CPR has a Debt to FCF ratio (8.49) which is comparable to the rest of the industry.
CPR has a Debt/Equity ratio of 0.64. This is a neutral value indicating CPR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.64, CPR is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Altman-Z | 2.56 |
ROIC/WACC1.06
WACC6.66%
2.3 Liquidity
CPR has a Current Ratio of 2.32. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CPR (2.32) is better than 87.10% of its industry peers.
A Quick Ratio of 0.91 indicates that CPR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.91, CPR belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -40.50% in the last year.
The Earnings Per Share has been decreasing by -8.12% on average over the past years.
The Revenue has been growing slightly by 5.18% in the past year.
The Revenue has been growing by 10.75% on average over the past years. This is quite good.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
3.2 Future
The Earnings Per Share is expected to grow by 11.51% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.25% on average over the next years.
EPS Next Y2.03%
EPS Next 2Y4.85%
EPS Next 3Y7.34%
EPS Next 5Y11.51%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y4.25%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CPR is valuated quite expensively with a Price/Earnings ratio of 33.82.
77.42% of the companies in the same industry are cheaper than CPR, based on the Price/Earnings ratio.
CPR is valuated rather expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
CPR is valuated rather expensively with a Price/Forward Earnings ratio of 17.62.
Based on the Price/Forward Earnings ratio, CPR is valued a bit more expensive than 64.52% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.88. CPR is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.82 | ||
| Fwd PE | 17.62 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPR is on the same level as its industry peers.
61.29% of the companies in the same industry are cheaper than CPR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.06 | ||
| EV/EBITDA | 11.66 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)16.68
PEG (5Y)N/A
EPS Next 2Y4.85%
EPS Next 3Y7.34%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.12%, CPR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.86, CPR's dividend is way lower than its industry peers. On top of this 80.65% of the companies listed in the same industry pay a better dividend than CPR!
With a Dividend Yield of 1.12, CPR pays less dividend than the S&P500 average, which is at 1.90.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CPR pays out 38.69% of its income as dividend. This is a sustainable payout ratio.
DP38.69%
EPS Next 2Y4.85%
EPS Next 3Y7.34%
BIT:CPR (1/9/2026, 7:00:00 PM)
5.75
-0.06 (-1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners23.2%
Inst Owner ChangeN/A
Ins Owners50.8%
Ins Owner ChangeN/A
Market Cap7.08B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts72.31
Price Target7.05 (22.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.51%
PT rev (3m)1.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.82 | ||
| Fwd PE | 17.62 | ||
| P/S | 2.31 | ||
| P/FCF | 22.06 | ||
| P/OCF | 10.86 | ||
| P/B | 1.91 | ||
| P/tB | 58.32 | ||
| EV/EBITDA | 11.66 |
EPS(TTM)0.17
EY2.96%
EPS(NY)0.33
Fwd EY5.68%
FCF(TTM)0.26
FCFY4.53%
OCF(TTM)0.53
OCFY9.21%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)16.68
PEG (5Y)N/A
Graham Number3.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROCE | 9.58% | ||
| ROIC | 7.03% | ||
| ROICexc | 7.57% | ||
| ROICexgc | 17.42% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 10.45% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | 230.39% | ||
| Cap/Sales | 10.79% | ||
| Interest Coverage | 6.41 | ||
| Cash Conversion | 81.69% | ||
| Profit Quality | 159.18% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.56 |
F-Score6
WACC6.66%
ROIC/WACC1.06
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y2.03%
EPS Next 2Y4.85%
EPS Next 3Y7.34%
EPS Next 5Y11.51%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y4.25%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year26.24%
EBIT Next 3Y12.26%
EBIT Next 5Y10.28%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%
DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.
What is the valuation status for CPR stock?
ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 4 / 10.
Can you provide the financial health for CPR stock?
The financial health rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 5 / 10.
Can you provide the expected EPS growth for CPR stock?
The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 2.03% in the next year.